Field evaluation of quantitative point of care diagnostics to measure glucose-6-phosphate dehydrogenase activity.

BACKGROUND:Glucose-6-Phosphate dehydrogenase (G6PD) deficiency is the most common enzymopathy worldwide, no reliable bedside diagnostic tests to quantify G6PD activity exist. This study evaluated two novel quantitative G6PD diagnostics. METHODS:Participants with known G6PD activity were enrolled in...

Full description

Bibliographic Details
Main Authors: Mohammad Shafiul Alam, Mohammad Golam Kibria, Nusrat Jahan, Kamala Thriemer, Mohammad Sharif Hossain, Nicholas M Douglas, Ching Swe Phru, Wasif Ali Khan, Ric N Price, Benedikt Ley
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC6214512?pdf=render
_version_ 1818059555734552576
author Mohammad Shafiul Alam
Mohammad Golam Kibria
Nusrat Jahan
Kamala Thriemer
Mohammad Sharif Hossain
Nicholas M Douglas
Ching Swe Phru
Wasif Ali Khan
Ric N Price
Benedikt Ley
author_facet Mohammad Shafiul Alam
Mohammad Golam Kibria
Nusrat Jahan
Kamala Thriemer
Mohammad Sharif Hossain
Nicholas M Douglas
Ching Swe Phru
Wasif Ali Khan
Ric N Price
Benedikt Ley
author_sort Mohammad Shafiul Alam
collection DOAJ
description BACKGROUND:Glucose-6-Phosphate dehydrogenase (G6PD) deficiency is the most common enzymopathy worldwide, no reliable bedside diagnostic tests to quantify G6PD activity exist. This study evaluated two novel quantitative G6PD diagnostics. METHODS:Participants with known G6PD activity were enrolled in Bangladesh. G6PD activity was measured by spectrophotometry, Biosensor (BS; AccessBio/CareStart, USA) and STANDARD G6PD (SG; SDBiosensor, ROK). G6PD activity was measured repeatedly in a subset of samples stored at room temperature and 4°C. RESULTS:158 participants were enrolled, 152 samples tested by BS, 108 samples by SG and 102 samples were tested by all three methods. In comparison to spectrophotometry BS had sensitivity and specificity of 72% (95%CI: 53-86) and 100% (95%CI: 97-100) at 30% cut off respectively, while SG had a sensitivity of 100% (95%CI: 88-100) and specificity of 97% (95%CI: 91-99) at the same cut off. The sensitivity and specificity at 70% cut off activity were 71% (95%CI: 59-82) and 98% (95%CI, 92-100) respectively for BS and 89% (95%CI: 77-96) and 93% (95%CI: 83-98) respectively for SG. When an optimal cut-off was applied the sensitivity of the BS at 70 cut off rose to 91% [95%CI: 80-96] and specificity to 82% [95%CI: 83-89]; a diagnostic accuracy comparable to that of the SG (p = 0.879). G6PD activity dropped significantly (-0.31U/gHb, 95%CI: -0.61 to -0.01, p = 0.022) within 24 hours in samples stored at room temperature, but did not fall below 90% of baseline activity until day 13 (-0.87U/gHb, 95%CI: (-1.11 to -0.62), p<0.001). CONCLUSION:BS and SG are the first quantitative diagnostics to measure G6PD activity reliably at the bedside and represent suitable alternatives to spectrophotometry in resource poor settings. If samples are stored at 4°C, G6PD activity can be measured reliably for at least 7 days after sample collection.
first_indexed 2024-12-10T13:18:23Z
format Article
id doaj.art-94d7605be85944b79a829f9920792f7c
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-10T13:18:23Z
publishDate 2018-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-94d7605be85944b79a829f9920792f7c2022-12-22T01:47:27ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-011311e020633110.1371/journal.pone.0206331Field evaluation of quantitative point of care diagnostics to measure glucose-6-phosphate dehydrogenase activity.Mohammad Shafiul AlamMohammad Golam KibriaNusrat JahanKamala ThriemerMohammad Sharif HossainNicholas M DouglasChing Swe PhruWasif Ali KhanRic N PriceBenedikt LeyBACKGROUND:Glucose-6-Phosphate dehydrogenase (G6PD) deficiency is the most common enzymopathy worldwide, no reliable bedside diagnostic tests to quantify G6PD activity exist. This study evaluated two novel quantitative G6PD diagnostics. METHODS:Participants with known G6PD activity were enrolled in Bangladesh. G6PD activity was measured by spectrophotometry, Biosensor (BS; AccessBio/CareStart, USA) and STANDARD G6PD (SG; SDBiosensor, ROK). G6PD activity was measured repeatedly in a subset of samples stored at room temperature and 4°C. RESULTS:158 participants were enrolled, 152 samples tested by BS, 108 samples by SG and 102 samples were tested by all three methods. In comparison to spectrophotometry BS had sensitivity and specificity of 72% (95%CI: 53-86) and 100% (95%CI: 97-100) at 30% cut off respectively, while SG had a sensitivity of 100% (95%CI: 88-100) and specificity of 97% (95%CI: 91-99) at the same cut off. The sensitivity and specificity at 70% cut off activity were 71% (95%CI: 59-82) and 98% (95%CI, 92-100) respectively for BS and 89% (95%CI: 77-96) and 93% (95%CI: 83-98) respectively for SG. When an optimal cut-off was applied the sensitivity of the BS at 70 cut off rose to 91% [95%CI: 80-96] and specificity to 82% [95%CI: 83-89]; a diagnostic accuracy comparable to that of the SG (p = 0.879). G6PD activity dropped significantly (-0.31U/gHb, 95%CI: -0.61 to -0.01, p = 0.022) within 24 hours in samples stored at room temperature, but did not fall below 90% of baseline activity until day 13 (-0.87U/gHb, 95%CI: (-1.11 to -0.62), p<0.001). CONCLUSION:BS and SG are the first quantitative diagnostics to measure G6PD activity reliably at the bedside and represent suitable alternatives to spectrophotometry in resource poor settings. If samples are stored at 4°C, G6PD activity can be measured reliably for at least 7 days after sample collection.http://europepmc.org/articles/PMC6214512?pdf=render
spellingShingle Mohammad Shafiul Alam
Mohammad Golam Kibria
Nusrat Jahan
Kamala Thriemer
Mohammad Sharif Hossain
Nicholas M Douglas
Ching Swe Phru
Wasif Ali Khan
Ric N Price
Benedikt Ley
Field evaluation of quantitative point of care diagnostics to measure glucose-6-phosphate dehydrogenase activity.
PLoS ONE
title Field evaluation of quantitative point of care diagnostics to measure glucose-6-phosphate dehydrogenase activity.
title_full Field evaluation of quantitative point of care diagnostics to measure glucose-6-phosphate dehydrogenase activity.
title_fullStr Field evaluation of quantitative point of care diagnostics to measure glucose-6-phosphate dehydrogenase activity.
title_full_unstemmed Field evaluation of quantitative point of care diagnostics to measure glucose-6-phosphate dehydrogenase activity.
title_short Field evaluation of quantitative point of care diagnostics to measure glucose-6-phosphate dehydrogenase activity.
title_sort field evaluation of quantitative point of care diagnostics to measure glucose 6 phosphate dehydrogenase activity
url http://europepmc.org/articles/PMC6214512?pdf=render
work_keys_str_mv AT mohammadshafiulalam fieldevaluationofquantitativepointofcarediagnosticstomeasureglucose6phosphatedehydrogenaseactivity
AT mohammadgolamkibria fieldevaluationofquantitativepointofcarediagnosticstomeasureglucose6phosphatedehydrogenaseactivity
AT nusratjahan fieldevaluationofquantitativepointofcarediagnosticstomeasureglucose6phosphatedehydrogenaseactivity
AT kamalathriemer fieldevaluationofquantitativepointofcarediagnosticstomeasureglucose6phosphatedehydrogenaseactivity
AT mohammadsharifhossain fieldevaluationofquantitativepointofcarediagnosticstomeasureglucose6phosphatedehydrogenaseactivity
AT nicholasmdouglas fieldevaluationofquantitativepointofcarediagnosticstomeasureglucose6phosphatedehydrogenaseactivity
AT chingswephru fieldevaluationofquantitativepointofcarediagnosticstomeasureglucose6phosphatedehydrogenaseactivity
AT wasifalikhan fieldevaluationofquantitativepointofcarediagnosticstomeasureglucose6phosphatedehydrogenaseactivity
AT ricnprice fieldevaluationofquantitativepointofcarediagnosticstomeasureglucose6phosphatedehydrogenaseactivity
AT benediktley fieldevaluationofquantitativepointofcarediagnosticstomeasureglucose6phosphatedehydrogenaseactivity